KIN12E Antibody

What is KIN12E and what is its role in plant cell division?

KIN12E is a kinesin protein that belongs to the POK-like family of kinesins in plants. It is closely related to Arabidopsis POK1, POK2, and KIN12E proteins. These kinesins play crucial roles in phragmoplast guidance during plant cell division. KIN12E specifically contributes to the proper orientation and guidance of the phragmoplast, which is essential for establishing the cell plate during cytokinesis in plant cells. The protein has been identified as a potential interactor with OPAQUE1/DISCORDIA2 myosin XI, suggesting its involvement in complex molecular machinery that coordinates cytoskeletal dynamics during cell division .

How does KIN12E differ structurally from related kinesins like KIN12C and KIN12D?

KIN12E is structurally distinct from its related kinesins KIN12C and KIN12D primarily in its size. While KIN12C and KIN12D have larger coding sequences of 5,766 and 8,163 base pairs respectively, KIN12E is considerably smaller. This size difference impacts experimental approaches, as demonstrated in yeast two-hybrid assays where researchers were able to use the full-length KIN12E protein while only C-terminal portions of KIN12C and KIN12D could be employed due to their large size. All three proteins share the characteristic N-terminal motor domain typical of kinesins, but likely differ in their C-terminal cargo-binding domains which determine their specific interactions and functions .

How does KIN12E interact with other cell division proteins?

KIN12E has been demonstrated to interact directly with OPAQUE1 (O1), a myosin XI motor protein involved in phragmoplast guidance. This interaction was confirmed through both co-immunoprecipitation studies and yeast two-hybrid assays. Additionally, KIN12E, along with KIN12C and KIN12D, has been identified as a direct interactor with TANGLED1 (TAN1), another key protein that marks the cortical division site during cell division. These interactions suggest that KIN12E functions within a protein complex that coordinates the cytoskeleton during cell division, potentially serving as a linker between actin-based and microtubule-based processes. The interaction network involving KIN12E is crucial for proper phragmoplast guidance and, consequently, accurate cell plate positioning .

What are the optimal immunoprecipitation conditions for detecting KIN12E interactions?

For optimal immunoprecipitation to detect KIN12E interactions, researchers should consider a dual-antibody approach to increase confidence in interaction data. Based on published protocols, successful detection of KIN12E in immunoprecipitates requires careful threshold setting, as KIN12E was detected with one antibody but fell just below the threshold cutoff for a second antibody in previous studies. For plant tissue samples, developing leaf tissue has proven effective for detecting KIN12E and its interactions. Researchers should perform multiple biological replicates and consider using both wild-type samples and negative controls (such as knockout mutants) to validate specific interactions. The immunoprecipitation buffer composition should be optimized to preserve transient protein-protein interactions while minimizing background. Quantification of peptide numbers from mass spectrometry analysis provides a reliable metric for assessing interaction strength .

How should researchers design antibody experiments to distinguish between KIN12E and its closely related family members?

Designing antibody experiments to distinguish between KIN12E and related kinesins like KIN12C and KIN12D requires careful consideration of specificity. Researchers should:

• Target unique epitopes in the C-terminal regions of KIN12E, as this region shows greater sequence divergence from KIN12C and KIN12D

• Validate antibody specificity using recombinant protein expression systems with tagged versions of each kinesin

• Perform cross-reactivity tests against all three proteins

• Include appropriate knockout controls in experiments to confirm antibody specificity

• Consider using peptide competition assays to verify epitope specificity

• Employ Western blotting to confirm that the antibody detects a protein of the expected molecular weight for KIN12E

• Use epitope tagging and orthogonal detection methods to confirm antibody results

For structural analyses, researchers should note that full-length KIN12E can be expressed in heterologous systems, unlike the larger KIN12C and KIN12D, providing an advantage for antibody target validation .

What controls are essential when using KIN12E antibodies in plant cell division studies?

Essential controls for KIN12E antibody experiments in plant cell division studies include:

• Genetic controls: Include KIN12E knockout/knockdown mutants to verify antibody specificity

• Competing epitope controls: Pre-incubate antibodies with purified KIN12E peptides to demonstrate binding specificity

• Secondary antibody-only controls: Verify that secondary antibodies don't produce non-specific signals

• Cross-reactivity controls: Test antibodies against recombinant KIN12C and KIN12D to ensure specificity

• Cell cycle stage controls: Compare signals across different stages of the cell cycle, as KIN12E localization is expected to change

• Isotype controls: Use non-specific antibodies of the same isotype to identify background binding

• Developmental stage controls: Sample tissues at different developmental stages, as expression levels of KIN12E may vary

• Wild-type versus mutant tissue comparisons: Analyze tissues with mutations in known interacting partners like OPAQUE1/DISCORDIA2 or TAN1

These controls help distinguish true signals from artifacts and ensure that experimental observations accurately reflect KIN12E biology in dividing plant cells .

How do post-translational modifications affect KIN12E function and antibody recognition?

Post-translational modifications (PTMs) of KIN12E may significantly impact both its biological function and antibody recognition. Although specific PTMs of KIN12E have not been extensively characterized in the provided search results, kinesins generally undergo phosphorylation, acetylation, and ubiquitination that regulate their motor activity, cargo binding, and protein stability.

For antibody recognition, researchers should consider:

• Phosphorylation-specific antibodies: These may be necessary to study cell-cycle dependent regulation of KIN12E

• Epitope masking: Some PTMs might mask antibody epitopes, leading to false-negative results

• Modification-induced conformational changes: These could expose or hide epitopes, affecting antibody binding

When designing experiments, researchers should:

• Use phosphatase treatments to determine if phosphorylation affects antibody recognition

• Consider developing modification-specific antibodies if particular PTMs prove functionally important

• Compare antibody binding across cell cycle stages when different modifications may be present

• Validate findings using mass spectrometry to identify specific modification sites

Understanding the interplay between PTMs and antibody recognition is critical for accurate interpretation of KIN12E localization and interaction studies .

What are the challenges in resolving contradictory data from different KIN12E antibody detection methods?

Resolving contradictory data from different KIN12E antibody detection methods requires systematic troubleshooting and methodological triangulation. Researchers frequently encounter discrepancies between immunoprecipitation, yeast two-hybrid, and immunolocalization results. As demonstrated with KIN12E, while co-immunoprecipitation suggested potential interaction with OPAQUE1, this had to be further validated through yeast two-hybrid assays.

To resolve such contradictions, researchers should:

• Compare epitope accessibility: Different experimental conditions may expose or mask epitopes

• Evaluate detection sensitivity thresholds: As seen with KIN12E, it was detected with one antibody but fell below threshold with another

• Cross-validate with orthogonal techniques: Combine immunological techniques with genetic approaches and direct binding assays

• Assess protein conformational states: Native versus denatured conditions can affect antibody recognition

• Consider protein complex context: Some interactions may only occur within larger protein complexes

• Examine experimental conditions: Buffer composition, salt concentration, and detergents can all affect results

• Perform quantitative comparison: Systematically analyze peptide numbers or binding affinities across methods

When KIN12E showed contradictory results between co-immunoprecipitation and yeast two-hybrid assays, researchers successfully resolved this by using the full-length KIN12E construct rather than just the C-terminal domain used for the related proteins .

How can researchers investigate the dynamics of KIN12E during different stages of phragmoplast development?

Investigating KIN12E dynamics during phragmoplast development requires advanced imaging techniques combined with specific antibodies. Researchers should consider:

• Live cell imaging: Generate fluorescently tagged KIN12E constructs (such as KIN12E-GFP) for time-lapse microscopy to track protein movements in real-time

• Stage-specific fixation protocols: Optimize fixation methods to preserve KIN12E localization at specific phragmoplast stages

• Co-localization studies: Use antibodies against phragmoplast markers (like tubulin) alongside KIN12E antibodies

• Super-resolution microscopy: Employ techniques like STORM or PALM to resolve KIN12E localization with nanometer precision

• Fluorescence Recovery After Photobleaching (FRAP): Measure KIN12E turnover rates at different phragmoplast regions

• Correlative light and electron microscopy: Combine immunofluorescence with electron microscopy for ultrastructural context

• Temporal inhibition studies: Use cell-cycle synchronized cultures with stage-specific inhibitors to capture discrete phases

Quantification methods should include:

• Measurement of KIN12E intensity along the phragmoplast over time

• Analysis of co-localization coefficients with other division proteins

• Tracking of KIN12E movement relative to the advancing cell plate

These approaches would provide comprehensive insights into how KIN12E contributes to phragmoplast guidance and cell plate formation .

How can researchers optimize immunohistochemistry protocols for KIN12E detection in plant tissues?

Optimizing immunohistochemistry for KIN12E detection in plant tissues requires several specialized considerations:

• Fixation optimization: Test crosslinking fixatives (paraformaldehyde) versus precipitating fixatives (methanol) to determine which best preserves KIN12E epitopes while maintaining tissue architecture

• Cell wall considerations: Include appropriate cell wall digestion steps (using enzymes like cellulase and pectolyase) to improve antibody penetration

• Antigen retrieval methods: Evaluate heat-induced versus protease-based antigen retrieval to expose masked epitopes

• Blocking optimization: Test different blocking agents (BSA, normal serum, milk proteins) to reduce plant-specific background

• Antibody dilution series: Perform systematic titration of primary antibodies to determine optimal signal-to-noise ratio

• Signal amplification: Consider tyramide signal amplification for low-abundance targets like KIN12E

• Permeabilization protocol: Optimize detergent type (Triton X-100, Tween-20) and concentration for balanced membrane permeabilization

• Incubation conditions: Test various temperature and time combinations for primary antibody binding

Include these validation steps:

• Parallel processing of wild-type and kin12e mutant tissues

• Pre-adsorption controls with recombinant KIN12E protein

• Comparison with fluorescent protein fusion localization patterns

For dividing cells specifically, researchers should synchronize tissues when possible and identify mitotic cells using DNA staining to systematically analyze KIN12E localization during cell division .

What approaches can be used to develop highly specific monoclonal antibodies against KIN12E?

Developing highly specific monoclonal antibodies against KIN12E requires strategic epitope selection and rigorous screening protocols:

• Antigen design strategy:

  • Target unique regions in the C-terminal domain that differ from KIN12C and KIN12D

  • Consider using multiple peptide antigens from different regions of KIN12E

  • Evaluate both conventional peptide immunization and recombinant protein approaches

• Immunization and screening protocol:

  • Implement a rigorous counter-screening process against KIN12C and KIN12D proteins

  • Use both ELISA and Western blot methods to confirm specificity

  • Include competitive binding assays with related kinesin proteins

• Advanced selection techniques:

  • Consider phage display technology for antibody generation with precise epitope targeting

  • Employ single B-cell sorting and sequencing approaches as described in contemporary antibody development methods

  • Use next-generation sequencing to analyze antibody repertoires

• Validation strategy:

  • Test antibodies on tissues from knockout mutants

  • Perform immunoprecipitation followed by mass spectrometry to confirm target specificity

  • Evaluate antibody performance across multiple experimental platforms (IP, IHC, Western blot)

Recent innovations in antibody development, such as the cryoEM-based approach detailed in search result , could be particularly valuable. This method combines structural data from cryoEM with next-generation sequencing to identify monoclonal antibodies from polyclonal sera, potentially offering a more direct path to obtaining specific antibodies against challenging targets like KIN12E .

What are the best approaches for quantifying KIN12E protein levels in plant extracts?

Quantifying KIN12E protein levels in plant extracts requires selecting appropriate methods based on research goals and sample limitations:

• Western blotting with internal controls:

  • Use housekeeping proteins as loading controls

  • Implement standard curves with recombinant KIN12E protein

  • Employ fluorescent secondary antibodies for wider linear detection range

  • Validate signal specificity with knockout mutants

• Mass spectrometry-based quantification:

  • Implement Selected Reaction Monitoring (SRM) for targeted KIN12E peptide quantification

  • Use stable isotope-labeled internal standards for absolute quantification

  • Consider Data Independent Acquisition (DIA) for comprehensive protein profiling

  • Sample preparation should include optimized extraction buffers to solubilize membrane-associated kinesins

• ELISA methodologies:

  • Develop sandwich ELISA using two antibodies targeting different KIN12E epitopes

  • Establish standard curves using purified recombinant KIN12E

  • Implement competitive ELISA for samples with potential interfering proteins

Quantitative comparison table across methods:

For developmental studies tracking KIN12E across plant growth stages, researchers should standardize tissue collection, homogenization techniques, and extraction buffers to ensure comparable results across samples .

How can researchers address non-specific binding when using KIN12E antibodies?

Non-specific binding is a common challenge when working with KIN12E antibodies in plant systems. To address this issue effectively:

• Optimize blocking conditions:

  • Test different blocking agents (BSA, casein, normal serum)

  • Increase blocking time and concentration for particularly problematic samples

  • Consider specialized plant-specific blocking reagents that account for endogenous biotin and peroxidases

• Antibody purification approaches:

  • Perform affinity purification of antibodies against immobilized KIN12E peptides

  • Consider pre-adsorption with plant extracts from kin12e mutants to remove antibodies that recognize non-specific plant proteins

  • Use protein A/G purification to isolate the IgG fraction for cleaner results

• Buffer optimization strategy:

  • Increase detergent concentration (Tween-20, Triton X-100) in wash buffers

  • Test different salt concentrations to disrupt low-affinity non-specific interactions

  • Adjust pH conditions to optimize specific binding while minimizing background

• Detection system modifications:

  • Switch from colorimetric to fluorescent detection for better signal discrimination

  • Use directly conjugated primary antibodies to eliminate secondary antibody cross-reactivity

  • Consider tyramide signal amplification for specific enhancement of true signals

• Validation controls:

  • Always include kin12e mutant samples as negative controls

  • Perform peptide competition assays to confirm signal specificity

  • Include isotype control antibodies to identify Fc receptor-mediated binding

When non-specific binding persists despite these measures, molecular approaches like epitope tagging of endogenous KIN12E through CRISPR-based genome editing may provide an alternative strategy for specific detection .

What are common pitfalls in interpreting KIN12E antibody results in co-localization studies?

Interpreting KIN12E antibody results in co-localization studies presents several potential pitfalls that researchers should actively address:

• Optical resolution limitations:

  • Conventional microscopy's resolution limit (~200nm) may suggest co-localization where proteins are actually separated

  • Super-resolution techniques should be employed for definitive co-localization claims

  • Always calculate and report point spread function measurements for the optical system used

• Chromatic aberration effects:

  • Different wavelengths focus at slightly different planes, creating false co-localization

  • Use appropriate chromatic aberration correction methods and controls

  • Consider spectral unmixing for closely overlapping fluorophores

• Statistical interpretation challenges:

  • Pearson's correlation coefficient may be insufficient; consider Manders' coefficients or object-based approaches

  • Establish quantitative thresholds for meaningful co-localization

  • Report co-localization metrics with appropriate statistical tests across multiple cells/samples

• Sample preparation artifacts:

  • Fixation can alter protein localization patterns

  • Cross-validate fixed sample results with live-cell imaging when possible

  • Test multiple fixation protocols to confirm consistent localization patterns

• Antibody cross-reactivity concerns:

  • Apparent co-localization may result from antibody cross-reactivity with related proteins

  • Include appropriate controls with single-antibody staining

  • Verify results with alternative detection methods (e.g., fluorescent protein fusions)

• Cell cycle stage variability:

  • KIN12E localization likely changes dramatically during cell division

  • Always document and classify cell cycle stage for each analyzed cell

  • Compare co-localization patterns across different cell cycle stages

To overcome these challenges, researchers should implement rigorous controls, quantitative analysis, and orthogonal validation approaches .

How can researchers validate that their KIN12E antibody is detecting the correct protein in their experimental system?

Validating KIN12E antibody specificity requires a multi-faceted approach combining genetic, biochemical, and analytical methods:

• Genetic validation approaches:

  • Test antibody on knockout/knockdown mutants (should show reduced/absent signal)

  • Complement mutants with tagged KIN12E and confirm co-localization with antibody signal

  • Use CRISPR-Cas9 to tag endogenous KIN12E and verify antibody recognition patterns

• Biochemical validation methods:

  • Perform immunoprecipitation followed by mass spectrometry to identify pulled-down proteins

  • Conduct Western blot analysis to confirm the antibody detects a protein of the expected molecular weight

  • Use recombinant KIN12E protein as a positive control in assays

• Cross-reactivity assessment:

  • Test against recombinant KIN12C and KIN12D proteins to evaluate potential cross-reactivity

  • Perform peptide competition assays with specific KIN12E peptides versus related kinesin peptides

  • Consider heterologous expression systems to test antibody specificity

• Orthogonal validation techniques:

  • Compare antibody localization patterns with fluorescently tagged KIN12E

  • Validate protein-protein interactions detected by co-immunoprecipitation with alternative methods like yeast two-hybrid assays

  • Correlate antibody signal with mRNA expression using in situ hybridization

A comprehensive validation strategy is particularly important for KIN12E given its similarity to other kinesins. As demonstrated in the literature, KIN12E interactions with OPAQUE1 required validation through multiple methods, including both co-immunoprecipitation and yeast two-hybrid assays to confirm specificity and rule out false positives .

How might new imaging technologies enhance KIN12E antibody-based research?

Emerging imaging technologies offer transformative potential for KIN12E antibody research:

• Super-resolution microscopy advancements:

  • Techniques like STORM, PALM, and STED microscopy can resolve KIN12E localization with 10-20nm precision

  • DNA-PAINT approaches allow for multiplexed imaging of KIN12E alongside numerous interacting partners

  • Expansion microscopy physically enlarges samples to achieve effective super-resolution with standard microscopes

• Live-cell imaging innovations:

  • Lattice light-sheet microscopy enables long-term 3D imaging with minimal phototoxicity

  • Antibody fragments (Fabs, nanobodies) conjugated to bright fluorophores allow live-cell immunolabeling

  • FRET-based sensors can detect KIN12E conformational changes or interactions in real-time

• Correlative microscopy approaches:

  • Correlative Light and Electron Microscopy (CLEM) combines immunofluorescence with ultrastructural context

  • Focused Ion Beam-Scanning Electron Microscopy (FIB-SEM) with immunogold labeling provides 3D ultrastructural context

  • Cryo-electron tomography of immunolabeled samples enables structural studies in near-native state

• Advanced image analysis methods:

  • Machine learning algorithms for automated detection of KIN12E localization patterns

  • Single-particle tracking for analyzing KIN12E dynamics

  • Quantitative co-localization with statistical validation

• Multiplexed imaging technologies:

  • Cyclic immunofluorescence or mass cytometry techniques allow simultaneous analysis of dozens of proteins

  • Spectral imaging combined with linear unmixing enables separation of closely overlapping fluorophores

  • Sequential detection methods with antibody elution and reprobing

These technologies would enable researchers to analyze KIN12E's dynamic behavior during phragmoplast guidance with unprecedented spatial and temporal resolution, potentially revealing previously undetectable mechanistic details of its function .

What are promising approaches for studying post-translational modifications of KIN12E?

Studying post-translational modifications (PTMs) of KIN12E requires sophisticated methodological approaches combining antibody-based detection with advanced analytical techniques:

• Modification-specific antibodies:

  • Develop antibodies targeting specific predicted phosphorylation, acetylation, or ubiquitination sites on KIN12E

  • Validate modification-specific antibodies using in vitro modified recombinant KIN12E

  • Implement phospho-state specific antibodies to monitor regulatory phosphorylation events

• Mass spectrometry approaches:

  • Employ enrichment strategies (e.g., titanium dioxide for phosphopeptides) prior to MS analysis

  • Implement parallel reaction monitoring for targeted quantification of modified peptides

  • Use top-down proteomics to analyze intact KIN12E with its modification patterns preserved

• Genetic manipulation strategies:

  • Generate phosphomimetic and phospho-null mutants at predicted regulatory sites

  • Use CRISPR-Cas9 to introduce specific modifications at endogenous loci

  • Evaluate phenotypic consequences of disrupting specific PTM sites

• Biochemical characterization:

  • Compare motor activity, microtubule binding, and ATPase activity of differently modified KIN12E forms

  • Analyze how PTMs affect protein-protein interactions, particularly with OPAQUE1 and TAN1

  • Develop in vitro systems to reconstitute regulatory mechanisms

• Temporal dynamics analysis:

  • Track modification status through cell cycle stages using synchronized cell cultures

  • Implement optogenetic tools to manipulate kinase/phosphatase activity with spatial and temporal precision

  • Develop biosensors to monitor KIN12E modification status in real-time

These approaches would provide critical insights into how KIN12E activity is regulated during cell division, potentially revealing therapeutic targets for modulating plant growth and development .

How can researchers integrate KIN12E antibody data with other -omics approaches for systems-level understanding?

Integrating KIN12E antibody data with multi-omics approaches enables a comprehensive systems-level understanding of its function in plant cell division networks:

• Proteomics integration strategies:

  • Combine KIN12E interactome data from immunoprecipitation with global protein expression profiles

  • Correlate KIN12E post-translational modifications with changing interaction partners

  • Map KIN12E into protein complexes identified through proximity labeling approaches

  • Create dynamic protein interaction networks across cell cycle stages

• Transcriptomics correlation approaches:

  • Analyze co-expression patterns between KIN12E and potential interactors

  • Identify transcription factors regulating KIN12E expression

  • Compare transcriptome changes in kin12e mutants with antibody-based protein localization data

  • Develop integrated regulatory networks combining transcriptional and post-translational control

• Functional genomics integration:

  • Correlate CRISPR screens phenotypes with KIN12E antibody localization patterns

  • Map genetic interaction networks onto physical interaction data

  • Connect KIN12E activity to specific cellular phenotypes through multiparametric imaging

• Structural biology synthesis:

  • Combine cryoEM structural data with antibody epitope mapping

  • Model KIN12E conformational changes based on antibody accessibility in different conditions

  • Develop structural models of KIN12E complexes guided by interaction data

• Computational integration frameworks:

  • Implement machine learning algorithms to predict KIN12E function from integrated datasets

  • Develop mathematical models of phragmoplast dynamics incorporating KIN12E localization data

  • Create visualization tools for exploring multi-dimensional KIN12E datasets

This integrated approach would enable researchers to position KIN12E within the broader regulatory network controlling plant cell division, providing a more complete understanding of its functional significance and potential applications in agricultural biotechnology .